Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Advanced Cancer × vistusertib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Stomach Neoplasms 2 Solid Tumor 2 Neoplasms 2 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Prostatic Neoplasms 1 Non-small Cell Lung Cancer Metastatic 1 Meningioma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Lung Neoplasms 1 Estrogen Receptor Positive Breast Cancer 1 Endometrial Neoplasms 1 Disease 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Breast Neoplasms 1 Advanced Cancer 1 Adenocarcinoma 1

Interventions

Surveys and Questionnaires 7 Bevacizumab 5 temsirolimus 4 Standard of Care 4 Sirolimus 4 Interviews as Topic 4 Vorinostat 2 Paclitaxel 2 Magnetic Resonance Spectroscopy 2 Everolimus 2 Erlotinib Hydrochloride 2 Cetuximab 2 zaleplon 1 vistusertib 1 tilsotolimod 1 pazopanib 1 olaparib 1 liposomal doxorubicin 1 capivasertib 1 apatinib 1 Videotape Recording 1 Vemurafenib 1 Valproic Acid 1 Trastuzumab 1 Topotecan 1 Temozolomide 1 Sunitinib 1 Sorafenib 1 Rehabilitation 1 Referral and Consultation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02193633 2024-09-26

TAX-TORC

Royal Marsden NHS Foundation Trust

Phase 1 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡